Marrone Bio Innovations to Present at The MicroCap Conference in New York on April 9th

DAVIS, Calif., April 02, 2018 -- Marrone Bio Innovations, Inc. (the “Company” or “MBI”) (NASDAQ:MBII), a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets, today announced that management is scheduled to present at The MicroCap Conference in New York City. The conference is being held on April 9-10, 2018 at the JW Marriott Essex House.

Marrone Bio Innovations management will host one-on-one meetings throughout the day and is scheduled to present as follows:

The MicroCap Conference
Date: Monday, April 9, 2018
Presentation Time: 9:00 a.m. Eastern time
Location: Track 3, JW Marriott Essex House – 160 Central Park S, New York, NY
Webcast: http://www.investorcalendar.com/event/27275

Registration is mandatory for conference participation. For more information on the conference or to schedule a one-on-one meeting, please visit the conference website, http://microcapconf.com.

About Marrone Bio Innovations
BIO WITH BITE.
Marrone Bio Innovations, Inc. (NASDAQ:MBII) strives to lead the movement to a more sustainable world through the discovery, development and promotion of biological products for pest management and plant health. MBI’s effective and environmentally responsible pest management solutions help customers operate more sustainably while uniquely improving plant health and increasing crop yields. MBI’s currently available commercial products are Regalia®, Grandevo®, Venerate®, Majestene®, Haven® Stargus^TM, Amplitude^TM, Zelto^TM and Zequanox®. MBI also distributes Bio-tam 2.0® for Isagro USA and Jet-Ag® for Jet Harvest in most regions of the U.S.

Marrone Bio Innovations is dedicated to pioneering smart biopesticide solutions that support a better tomorrow for both farmers and consumers around the globe.  For more information, please visit www.marronebio.com.

Marrone Bio Innovations Contacts:
Pam Marrone, CEO and Founder
Telephone: +1 (530) 750-2800
Email: [email protected]

Investor Relations:
Greg Falesnik
Managing Director
MZ Group – MZ North America
Main: 949-385-6449
[email protected]         
www.mzgroup.us